glp-1 and menopause Medications Weight Gain: What You Need to Know Are you navigating menopause while

Learn common, moderate, and serious risks, plus tips to manage symptoms safely.

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

Heads of State adopted a new Political Declaration under the 2030 Agenda for Sustainable Development - to reduce premature NCD mortality by one-third by 2030

A major new study reveals that women who discontinued these medications gained over 3 kg more during pregnancy compared to those who never used them

Chicory inulin

Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk